Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Frantisek Kovar"'
Autor:
Lucia Stančiaková, Jan Stasko, Ingrid Skornova, Matej Samoš, L Vadelova, Frantisek Kovar, Peter Galajda, Peter Kubisz, Tomáš Bolek, M. Mokan, Lukáš Urban, Radoslava Šimonová, Jana Zolkova
Publikováno v:
Acta Medica Martiniana, Vol 18, Iss 2, Pp 34-39 (2018)
Objectives: Several studies have questioned the need for platelet function testing in patients treated with new ADP receptor blockers (ADPRB). The aim of this study was to evaluate the prevalence of high on-treatment platelet reactivity (HTPR) among
Autor:
M. Mokan, Frantisek Kovar, Jan Stasko, Juraj Sokol, Marian Mokan, Frantisek Nehaj, Jela Ivankova
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis
The availability of direct oral anticoagulants has caused a paradigm shift in the management of thrombosis. Rivaroxaban and apixaban are 2 direct oral anticoagulants whose target specificity is activated factor X (FXa). However, it is still not fully
Autor:
Marianna Kubašková, Stanislav Mizera, M. Mokan, Veronika Jankovičová, Juraj Sokol, Frantisek Nehaj, Marian Mokan, Frantisek Kovar
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2018 (2018)
BioMed Research International, Vol 2018 (2018)
The patient database at the First Department of Internal Medicine in Martin, the Central Slovak Institute for Cardiac and Vascular Diseases in Banska Bystrica, and the National Slovak Institute of Cardiovascular Diseases in Bratislava was searched to
Publikováno v:
Zoosystematics and Evolution, Vol 99, Iss 1, Pp 45-53 (2023)
Six species of scorpion (Arachnida: Scorpiones) are documented from eighteen localities in seven different states within the Republic of the Sudan. Combining this new data with historical records in the Sudan Natural History Museum and the published
Externí odkaz:
https://doaj.org/article/3838fa2c1ed74c999dda555f263c0446
Review of the Pharmacology of the Emerging Possibilities of the Direct Oral Anticoagulants' Reversal
Autor:
Jan Stasko, Frantisek Kovar, Matej Samoš, Ingrid Skornova, Marian Mokan, Lucia Stančiaková, Tomáš Bolek, Peter Kubisz, Peter Galajda
Publikováno v:
Current drug metabolism. 18(7)
Background: Direct oral anticoagulants (DOACs) offer consistent and predictable anticoagulation, oral administration with good patient compliance and a good safety profile. Dabigatran – a direct thrombin inhibitor, apixaban and rivaroxaban – dire
Autor:
Rolf Wachter, Gerald Tremblay, Harry Shi, Anoop Chauhan, Antonio Fernández Ortiz, Miguel Fiol Sala, Jerzy Lewczuk, Andrew Grieve, Rainer Hambrecht, Pierre Coste, Jean-Philippe Collet, J. M. Ten Berg, Jan Vojacek, J. Herrman, Witold Zmuda, Juan Ramon Rey Blas, Emmanuel Teiger, Jaroslav Sumbal, David Smith, Faiez Zannad, Geza Lupkovics, Karol Micko, Johann Bauersachs, Minakshi Madan, Cosme Garcia Garcia, Jerzy Gorny, Marcus Flather, Robert C. Welsh, Carlos Perez Muñoz, David Fitchett, Ruth H. Strasser, Karsten Sydow, Robin A.P. Weir, Miguel Orri, Michel Barboteu, Thomas Münzel, Gilles Montalescot, Georg Noll, Harald Mudra, János Tomcsányi, Serge Lepage, W. Stuart Hillis, Jiri Kettner, Roman Margoczy, Csaba András Dézsi, Thomas N. Martin, Jacek Kubica, Gilles Zemour, Franciso Ridocci Soriano, Dawn L. Adamson, Stephan Steiner, Marian Hranai, Filippatos Gerasimos, Farqad Alamgir, Jean-Lucien Rouleau, Bruce Sussex, Martin Hutyra, Gregory Y.H. Lip, Dimitros Alexopoulos, Michael Böhm, Graham C. Wong, Dominique Ducos, Michel Galinier, Bertram Pitt, Eva Turgonyi, Petr Ostadal, Christian W. Hamm, Freek W.A. Verheugt, Carsten Tschöpe, Esteban López de Sá, Vlassios N Pyrgakis, Jindrich Spinar, Blair J. O'Neill, Hubertus Heuer, Gerhard Hauf, John Vincent, Nikos Werner, David E. Newby, Frantisek Kovar, Dimitrios Babalis, Yves Cottin, Peter Polgar, Gerry P McCann, Xavier Bosch Genover
Publikováno v:
European Heart Journal
European Heart Journal, 2014, 35 (34), pp.2295-2302. ⟨10.1093/eurheartj/ehu164⟩
European Heart Journal, Oxford University Press (OUP): Policy B, 2014, 35 (34), pp.2295-2302. ⟨10.1093/eurheartj/ehu164⟩
European Heart Journal, 2014, 35 (34), pp.2295-2302. ⟨10.1093/eurheartj/ehu164⟩
European Heart Journal, Oxford University Press (OUP): Policy B, 2014, 35 (34), pp.2295-2302. ⟨10.1093/eurheartj/ehu164⟩
International audience; AIMS:We aimed to assess the impact of eplerenone on cardiovascular (CV) outcomes in STEMI without known heart failure, when initiated within 24 h of symptom onset.METHODS AND RESULTS:In this randomized, placebo-controlled, dou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fb2312c3e0059a046fe64b78f40bc78
https://hal.univ-lorraine.fr/hal-01738642
https://hal.univ-lorraine.fr/hal-01738642
Autor:
Ivo Petrov, William J. French, Iftikhar O Ebrahim, Christophe Gaudin, Sunil V. Rao, Stephen D. Wiviott, Frantisek Kovar, Elaine B. Hoffman, Sema Güneri, Shamir R. Mehta, Marc Cohen, Christoph Bode, Philippe Gabriel Steg, Myung Ho Jeong, Hanoch Hod, Marc S. Sabatine, Róbert Gábor Kiss, Petr Widimsky, Prafulla Kerkar, James W. Hoekstra, Manel Sabaté, Jose C. Nicolau, Peep Laanmets, Juan M. Ruiz-Nodar, Gabriel Arturo Ramos Lopez, Witold Rużyłło, Karen C. Fanouillere, Murat Sezer, Claudio Cavallini, Jae Hyung Kim, Mikhail Ruda, Charles V. Pollack, José Luis Navarro Estrada, Angele Moryusef, Pascal Minini
Publikováno v:
JAMA. 310(11)
The optimal anticoagulant for patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) managed with an invasive strategy remains controversial.To compare the clinical efficacy and safety of otamixaban, a novel intravenous direct fac
Publikováno v:
What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease
Contrast induced nephropathy (CIN) is an important and well‐known complication in pa‐ tients with chronic renal insufficiency undergoing both coronary angiography and coronary interventions. The estimated incidence of CN after coronary angiograph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a147c2c070a7a47acc32e813fa54462
http://www.intechopen.com/articles/show/title/contrast-induced-nephropathy-risk-factors-clinical-implication-diagnostics-approach-prevention
http://www.intechopen.com/articles/show/title/contrast-induced-nephropathy-risk-factors-clinical-implication-diagnostics-approach-prevention
Autor:
Matej Samoš, Lukas Duraj, Jan Stasko, Skornova I, Marián Fedor, Tomáš Bolek, J. Fedorova, Peter Galajda, M. Mokan, Frantisek Kovar, Peter Kubisz
Publikováno v:
Journal of Hematology & Thromboembolic Diseases.
The activation and subsequent platelet aggregation plays a key role in the formation of arterial thrombosis and therefore is the key therapeutic target in the treatment of acute coronary syndromes. Dual antiplatelet therapy containing aspirin and P2Y
Autor:
Andrzej Budaj, Michelle L. O'Donoghue, Róbert Gábor Kiss, Julia F Kuder, Jean Francois Tanguay, John J. Lepore, Frantisek Kovar, Matthew A. Cavender, Marc P. Bonaca, Jose Lopez-Sendon, Jindrich Spinar, Marc S. Sabatine, Mikael Dellborg, Pierre Théroux, Ruchira Glaser, Jorge Antonio Gutierrez, Jennifer B. Shannon, Christian W. Hamm, Keith A.A. Fox, P. Gabriel Steg, Philip E. Aylward, Ton Oude Ophuis, Ian Laws, Kyung Ah Im, David A. Morrow, Alexandr Parkhomenko, Stephen D. Wiviott, Richard Davies, Latitude-Timi Investigators, Mikhail Ruda
Publikováno v:
JAMA. 315:1591
Importance p38 Mitogen-activated protein kinase (MAPK)–stimulated inflammation is implicated in atherogenesis, plaque destabilization, and maladaptive processes in myocardial infarction (MI). Pilot data in a phase 2 trial in non–ST elevation MI i